Avidity Biosciences, Inc. (RNA)
72.49
-0.02
(-0.03%)
USD |
NASDAQ |
Jan 20, 12:07
Avidity Biosciences Cash from Investing (Quarterly): -587.93M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Novartis AG | -858.23M |
| Dyne Therapeutics, Inc. | -37.96M |
| EXACT Sciences Corp. | -86.45M |
| Astria Therapeutics, Inc. | 52.25M |
| Intellia Therapeutics, Inc. | -0.741M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -156.17M |
| Cash from Financing (Quarterly) | 850.37M |
| Free Cash Flow | -592.26M |
| Free Cash Flow Per Share (Quarterly) | -1.138 |
| Free Cash Flow to Equity (Quarterly) | -201.72M |
| Free Cash Flow to Firm (Quarterly) | -156.88M |
| Free Cash Flow Yield | -6.22% |